5.55
+3.74%
Close of 9 Nov 2026, in EUR
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About Mediclin
Its shares trade on XETRA under the ticker MED.DE. It has been listed since 4 December 2000. In the fiscal year to 31 December 2025, it reported revenue of €784.5m and net income of €25.5m. At that date it held total assets of €879.7m and shareholders' equity of €248.9m.
MediClin AG engages in the operation of hospitals, rehabilitation clinics, care homes and medical centers. The company is headquartered in Offenburg, Baden-Wuerttemberg. The company went IPO on 2000-12-04. The firm operates more than 50 facilities across Germany. Its portfolio comprises hospitals (acute care), rehabilitation clinics, care homes and medical care centers. The Group also offers a range of specialist medical services, such as neurosurgery, as well as specialist facilities, including heart centers, early neurological rehabilitation facilities and a specialist orthopedic hospital. In addition to that, it offers specialist services in the area of neuroradiology, as well as in psychological sciences (psychosomatics and psychiatry), orthopedics, in the areas of Ear, nose, and throat (ENT), oncology (radiotherapy) and inner medicine (including cardiology, pneumology and endocrinology).
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 4 Dec 2000
- Employees
- 7,558
- Website
- mediclin.de ↗
Leadership
Pay as last reported
- Dr. Jan LierschChairman of the Supervisory Board, since 2019
- Dr. Joachim RammingChairman of the Management Board, Chief Executive Officer
- Mr. Hans HilpertVice Chairman of the Supervisory Board, Employee Representative, since 2002€17,250
- Mr. Tino FritzChief Financial Officer, Member of the Management Board
- Mr. Thomas PiefkeChief Operating Officer, Member of the Management Board
- Dipl. Kfm. Michael BockIndependent Member of the Supervisory Board€14,250
- Dr. Julia Dannath SchuhIndependent Member of the Supervisory Board
- Ms. Cornelia WolfIndependent Member of the Supervisory Board
- Ms. Walburga ErichsmeierMember of the Supervisory Board, Employee Representative, since 2012€12,264
- Mr. Joachim GemmelMember of the Supervisory Board
- Mr. Michael HerbstrittMember of the Supervisory Board
- Dr. Sigrid KrauseMember of the Supervisory Board, Employee Representative
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 46
- Environment
- 55
- Social
- 67
- Governance
- 16
- Direct emissions (scope 1)
- 16,387.37 t
- Energy emissions (scope 2)
- 6,550.62 t
- Value chain emissions (scope 3)
- 98,652.38 t
- Women in the workforce
- 42.3%
- Carbon reduction policy
- No
- Human rights policy
- Yes
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- Mediclin AG has a strong reputation in the healthcare industry due to its high-quality medical services and state-of-the-art facilities.
- The company has a large network of hospitals and clinics, allowing it to serve a wide range of patients and offer diverse medical specialties.
Weaknesses
- One weakness of Mediclin AG is its dependency on government contracts and reimbursements, which can be subject to changes in healthcare policies and regulations.
- The company may face challenges in maintaining consistent revenue growth as healthcare costs continue to rise and potential budget constraints arise.
Opportunities
- There is a growing demand for healthcare services, particularly in specialized areas such as geriatrics and mental health, which presents opportunities for Mediclin AG to expand its offerings.
- The company can also explore partnerships and collaborations with research institutions or technology companies to enhance its medical technologies and treatments.
Threats
- Increased competition within the healthcare industry poses a threat to Mediclin AG's market share and profitability.
- Changes in healthcare regulations and policies, as well as potential economic downturns, can also pose threats to the company's financial stability.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.